CLINICAL_TRIALS
research
· 2020-08-10
Clinical Trial Update: FASTER-Tlalpan Study in Mexico: HPV Vaccination Impact on Cervical Cancer Screening Program [Phase 4]
Summary
Phase 4 trial update on HPV vaccination impact within a cervical cancer screening program in Mexico.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Instituto Nacional de Salud Publica, Mexico | Conditions: Cervical Intraepithelial Neoplasia, HPV-Related Cervical Carcinoma | Phase 4 | Status: COMPLETED